Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Genocea Biosciences, Inc. (GNCA)

« Back to company index

GNCA Chatter Timeline

Stock Ticker for GNCA

Most Active Tweeters for GNCA

UserTweets
@TheMarketsDaily 3
@ZolmaxNews 2
@ChartMill 2
@stocknewstimes 2
@PolackSki 2

Recent Tweets for GNCA

ChartMill @ChartMill
Based on estimates for the next 2 years, $GNCA will show a very strong growth in EPS: 31.38% on average per year.… https://t.co/g13qDfBd3X
October 19th 2020, 8:10am
StockTipRobot @StockTipRobot
Complex analysis suggests you should buy Genocea Biosciences $GNCA #StockMarket
October 19th 2020, 7:10am
WatchlistN @WatchlistN
Genocea Biosciences $GNCA Stock Rating Lowered by Zacks Investment Research https://t.co/TLrfgZH7LX
October 18th 2020, 2:10am
TranscriptDaily @TranscriptDaily
Zacks Investment Research Lowers Genocea Biosciences $GNCA to Hold https://t.co/ampHgBPedM
October 17th 2020, 6:10am
dakotafinancial @dakotafinancial
Genocea Biosciences, Inc. $GNCA Short Interest Down 46.0% in September https://t.co/BReRVrfvCG
October 16th 2020, 3:10pm
stocknewstimes @stocknewstimes
Genocea Biosciences $GNCA Rating Lowered to Hold at Zacks Investment Research https://t.co/dVG0rSB9Pd
October 16th 2020, 7:10am
bbnsnews @bbnsnews
Zacks Investment Research Downgrades Genocea Biosciences $GNCA to Hold https://t.co/M3K9HNbDdi
October 16th 2020, 7:10am
TranscriptDaily @TranscriptDaily
Genocea Biosciences, Inc. $GNCA Expected to Post Earnings of -$0.24 Per Share https://t.co/sdYyR3Sb7P
October 15th 2020, 9:10am
stocknewstimes @stocknewstimes
Genocea Biosciences, Inc. $GNCA Expected to Post Earnings of -$0.24 Per Share https://t.co/K0gTFMFyeh
October 15th 2020, 9:10am
TheMarketsDaily @TheMarketsDaily
Genocea Biosciences, Inc. $GNCA Sees Large Drop in Short Interest https://t.co/ALLy0J2LMK
October 15th 2020, 8:10am
TheMarketsDaily @TheMarketsDaily
Genocea Biosciences $GNCA Downgraded by Zacks Investment Research to “Hold” https://t.co/Gx8ravNrYi
October 15th 2020, 7:10am
ZolmaxNews @ZolmaxNews
Genocea Biosciences $GNCA Rating Lowered to Hold at Zacks Investment Research https://t.co/35Yev0AGpY
October 15th 2020, 7:10am
ZolmaxNews @ZolmaxNews
Genocea Biosciences $GNCA Trading 5.2% Higher https://t.co/YIFLSG9pUb
October 15th 2020, 6:10am
investor6969 @investor6969
Genocea Announces Upcoming Data Presentations at Virtual SITC 2020 $GNCA https://t.co/0T03WosZiQ via @benzinga
October 14th 2020, 5:10pm
otcdynamics @otcdynamics
$GNCA Genocea Announces Upcoming Data Presentations at Virtual SITC 2020 https://t.co/q1CABRxk4r
October 14th 2020, 5:10pm
PolackSki @PolackSki
$GNCA GENOCEA ANNOUNCES UPCOMING DATA PRESENTATIONS AT VIRTUAL #SITC2020 https://t.co/xxGMmhajvE https://t.co/fT0BgxNzl3
October 14th 2020, 5:10pm
stock_titan @stock_titan
$GNCA Genocea Announces Upcoming Data Presentations at Virtual SITC 2020 https://t.co/ASgE6zT77W
October 14th 2020, 5:10pm
MojoTradin @MojoTradin
@Pharmdca @Pharmdca Have you looked into $GNCA
October 14th 2020, 11:10am
fireworkstrades @fireworkstrades
RT @semodough: $SAVA had the biggest % increase and $GNCA the biggest % decrease in short interest as a percentage of float, at +9.9% and -…
October 12th 2020, 11:10am
semodough @semodough
$SAVA had the biggest % increase and $GNCA the biggest % decrease in short interest as a percentage of float, at +9… https://t.co/kydSgPeK1E
October 12th 2020, 11:10am
TheMarketsDaily @TheMarketsDaily
Genocea Biosciences $GNCA Stock Passes Above 50 Day Moving Average of $2.34 https://t.co/YTPHLs2BbA
October 10th 2020, 11:10am
kylewdennis_fx @kylewdennis_fx
Lost $27 trying to scalp a move on $GNCA https://t.co/1M6KStYIpO
October 10th 2020, 3:10am
Gambiste1 @Gambiste1
RT @chrismg88: $GNCA took a position today
October 8th 2020, 7:10pm
chrismg88 @chrismg88
$GNCA took a position today
October 8th 2020, 6:10pm
PolackSki @PolackSki
Genocea Oct.’20 Corp. Pres’n up. Slide 31/33, “Initiated (GEN-011) phase I/IIa clinical trial”. $GNCA #GEN011… https://t.co/ONezYQ4pEf
October 7th 2020, 12:10pm
ChartMill @ChartMill
$GNCA: The EPS is expected to grow by 31.38% on average over the next 2 years. This is a very strong growth.… https://t.co/rOqs9QmRPN
October 6th 2020, 3:10am
TickerReport @TickerReport
Zacks Investment Research Downgrades Genocea Biosciences $GNCA to Hold https://t.co/IZBxZrU827
October 3rd 2020, 2:10am
PolackSki @PolackSki
@GenoceaBio @TheChipClark Will Genocea be presenting new data at #SITC2020? Thanks! $GNCA
October 2nd 2020, 10:10am
username5858 @username5858
$GNCA $OCGN picked up here for a swing
October 1st 2020, 12:10pm
ba_0830 @ba_0830
@TickerReport thanks all Zacks especially @ZacGalifianakis $GNCA https://t.co/wLCcH7tgJ1
September 30th 2020, 5:09pm
AlexStarcevic @AlexStarcevic
$gnca is a buy $2.35 #Biotechnology
September 30th 2020, 3:09pm
SADIFAnalytics @SADIFAnalytics
Will Genocea Biosciences Inc Perform Long Term? $GNCA https://t.co/wMccyI4y02
September 23rd 2020, 10:09am
1stOncology @1stOncology
#Genocea Announces #FDA Acceptance of #GEN011 #InvestigationalNewDrugApplication $GNCA https://t.co/9YEPtAhSBq
September 23rd 2020, 6:09am
HealthcareBeat @HealthcareBeat
Genocea on go with early-stage study of cancer candidate GEN-011 $GNCA https://t.co/oWwidNfuDk
September 23rd 2020, 4:09am
ConsumerFeed @ConsumerFeed
Traders Buy High Volume of Genocea Biosciences Call Options $GNCA https://t.co/owoTodAv8e
September 23rd 2020, 1:09am
MaisaCorp @MaisaCorp
$GNCA the US Food and Drug Administration has accepted the company's investigational new drug application for GEN-0… https://t.co/QhiVyoMEh5
September 22nd 2020, 4:09pm
AmericanBanking @AmericanBanking
Genocea Biosciences $GNCA Shares Gap Up to $2.32 https://t.co/6O4UZMsvZW #stocks
September 22nd 2020, 10:09am
percent__b @percent__b
RT @Briefingcom: $GNCA: Genocea Biosciences: FDA has accepted its IND application for GEN-011 https://t.co/K66jaov9eD
September 22nd 2020, 9:09am
NewsQuantified @NewsQuantified
$GNCA Announces FDA Acceptance of GEN-011 IND Application, stock shoots +6.46% https://t.co/AP4dkQIKjj
September 22nd 2020, 9:09am
Briefingcom @Briefingcom
$GNCA: Genocea Biosciences: FDA has accepted its IND application for GEN-011 https://t.co/K66jaov9eD
September 22nd 2020, 9:09am
TipRanks @TipRanks
Genocea Up 5% On FDA Nod For Cancer Therapy Application; Street Sees 353% Upside https://t.co/WBDpoHLCJb $GNCA
September 22nd 2020, 9:09am
investor6969 @investor6969
Genocea Announces FDA Acceptance of GEN-011 IND Application $GNCA https://t.co/cayNDu5bko via @benzinga
September 22nd 2020, 8:09am
HealthcareBeat @HealthcareBeat
FDA accepts Genocea' application to initiate early-stage study for GEN-011 in cancer $GNCA https://t.co/OUH6HbdLV8
September 22nd 2020, 7:09am
MarketCurrents @MarketCurrents
$GNCA - FDA accepts Genocea' application to initiate early-stage study for GEN-011 in cancer https://t.co/FFhmSlKv6B
September 22nd 2020, 7:09am
otcdynamics @otcdynamics
$GNCA Genocea Announces FDA Acceptance of GEN-011 IND Application https://t.co/W6dSC4arYo
September 22nd 2020, 7:09am
HottestStockNow @HottestStockNow
FDA Accepts $GNCA 's IND Application for GEN-011, an adoptive T cell therapy targeting neoantigens… https://t.co/440RaxgbL1
September 22nd 2020, 7:09am
FlashAlert_me @FlashAlert_me
$GNCA [15s. delayed] filed form 8-K on September 22, 07:36:46: Item7.01: Regulation FD https://t.co/SjzVxQ0EWE
September 22nd 2020, 7:09am
EdgarInsider @EdgarInsider
Filing for 8-K [Press/News Current Report] has been made with the SEC: $GNCA GENOCEA BIOSCIENCES, INC https://t.co/U4IRnejBGz
September 22nd 2020, 7:09am
sbwcws @sbwcws
Genocea announces FDA acceptance of GEN-011 IND application $GNCA
September 22nd 2020, 7:09am
Stevema41911913 @Stevema41911913
RT @HealthcareBeat: Genocea Announces FDA Acceptance of GEN-011 IND Application $GNCA https://t.co/S9sEIZgc50
September 22nd 2020, 7:09am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.